Localization of the fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3

被引:26
作者
Hejna, JA
Timmers, CD
Reifsteck, C
Bruun, DA
Lucas, LW
Jakobs, PM
Toth-Fejel, S
Unsworth, N
Clemens, SL
Garcia, DK
Naylor, SL
Thayer, MJ
Olson, SB
Grompe, M
Moses, RE
机构
[1] Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, San Antonio, TX USA
关键词
D O I
10.1086/302896
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fanconi anemia (FA) is a rare autosomal recessive disease manifested by bone-marrow failure and an elevated incidence of cancer. Cells taken from patients exhibit spontaneous chromosomal breaks and rearrangements. These breaks and rearrangements are greatly elevated by treatment of FA cells with the use of DNA cross-linking agents. The FA complementation group D gene (FANCD) has previously been localized to chromosome 3p22-26, by use of microcell-mediated chromosome transfer. Here we describe the use of noncomplemented microcell hybrids to identify small overlapping deletions that narrow the FANCD critical region. A 1.2-Mb bacterial-artificial-chromosome (BAC)/P1 contig was constructed, bounded by the marker D3S3631 distally and by the gene ATP2B2 proximally. The contig contains at least 36 genes, including the oxytocin receptor (OXTR), hOGG1, the von Hippel-Lindau tumor-suppressor gene (VHL), and IRAK-2. Both hOGG1 and IRAK-2 were excluded as candidates for FANCD. BACs were then used as probes for FISH analyses, to map the extent of the deletions in four of the noncomplemented microcell hybrid cell lines. A narrow region of common overlapping deletions limits the FANCD critical region to similar to 200 kb. The three candidate genes in this region are TIGR-A004X28, SGC34603, and AA609512.
引用
收藏
页码:1540 / 1551
页数:12
相关论文
共 49 条
  • [1] Aburatani H, 1997, CANCER RES, V57, P2151
  • [2] ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
  • [3] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [4] DETERMINATION OF THE NUCLEOTIDE-SEQUENCE AND CHROMOSOMAL LOCALIZATION OF THE ATP2B2 GENE ENCODING HUMAN CA2+-PUMPING ATPASE ISOFORM PMCA2
    BRANDT, P
    IBRAHIM, E
    BRUNS, GAP
    NEVE, RL
    [J]. GENOMICS, 1992, 14 (02) : 484 - 487
  • [5] Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups
    Carreau, M
    Alon, N
    Bosnoyan-Collins, L
    Joenje, H
    Buchwald, M
    [J]. MUTATION RESEARCH-DNA REPAIR, 1999, 435 (01): : 103 - 109
  • [6] COHEN MM, 1982, AM J HUM GENET, V34, P794
  • [7] A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs
    Coquelle, A
    Toledo, F
    Stern, S
    Bieth, A
    Debatisse, M
    [J]. MOLECULAR CELL, 1998, 2 (02) : 259 - 265
  • [8] The Fanconi anaemia group G gene FANCG is identical with XRCC9
    de Winter, JP
    Waisfisz, Q
    Rooimans, MA
    van Berkel, CGM
    Bosnoyan-Collins, L
    Alon, N
    Carreau, M
    Bender, O
    Demuth, I
    Schindler, D
    Pronk, JC
    Arwert, F
    Hoehn, H
    Digweed, M
    Buchwald, M
    Joenje, H
    [J]. NATURE GENETICS, 1998, 20 (03) : 281 - 283
  • [9] A physical map of 30,000 human genes
    Deloukas, P
    Schuler, GD
    Gyapay, G
    Beasley, EM
    Soderlund, C
    Rodriguez-Tomé, P
    Hui, L
    Matise, TC
    McKusick, KB
    Beckmann, JS
    Bentolila, S
    Bihoreau, MT
    Birren, BB
    Browne, J
    Butler, A
    Castle, AB
    Chiannilkulchai, N
    Clee, C
    Day, PJR
    Dehejia, A
    Dibling, T
    Drouot, N
    Duprat, S
    Fizames, C
    Fox, S
    Gelling, S
    Green, L
    Harrison, P
    Hocking, R
    Holloway, E
    Hunt, S
    Keil, S
    Lijnzaad, P
    Louis-Dit-Sully, C
    Ma, J
    Mendis, A
    Miller, J
    Morissette, J
    Muselet, D
    Nusbaum, HC
    Peck, A
    Rozen, S
    Simon, D
    Slonim, DK
    Staples, R
    Stein, LD
    Stewart, EA
    Suchard, MA
    Thangarajah, T
    Vega-Czarny, N
    [J]. SCIENCE, 1998, 282 (5389) : 744 - 746
  • [10] Precise localisation of 3p25 breakpoints in four patients with the 3p-syndrome
    Drumheller, T
    McGillivray, BC
    Behrner, D
    MacLeod, P
    McFadden, DE
    Roberson, J
    Venditti, C
    Chorney, K
    Chorney, M
    Smith, DI
    [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (10) : 842 - 847